BROOMFIELD, Colo., April 05, 2016 -- As scientific evidence continues to prove that cannabidiol (CBD) is an essential part of good nutrition, more people are looking for the best CBD they can find. The good news for residents of Puerto Rico is that a new partnership now gives them access to the highest-quality CBD on the planet.
|
||||||
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/5c55d009-efa9-4fd4-95cd-b098e3d1c0d5
http://www.globenewswire.com/NewsRoom/AttachmentNg/242f2c98-e12c-465c-b663-b9f65bc71800
“For decades, Elixinol has been sourcing the best hemp in the world,” said Elixinol co-founder Paul Benhaim. “We continue to develop the most pure, most effective CBD products available anywhere. We are committed to delivering only the best CBD products to our growing family of customers around the world, and we are proud to partner with MAF Distributors to bring Elixinol to the people of Puerto Rico.”
The agreement gives MAF Distributors exclusive rights to market and sell Elixinol products, including CBD Capsules, Hemp Oil Tinctures, Hemp Oil Oral Applicators, and the new Hemp Oil Liposomes, in locations across the Commonwealth of Puerto Rico.
“We are pleased to bring Elixinol products to Puerto Rico,” said Miguel Feliciano, President of MAF Distributors. “We appreciate and value all the experience that Elixinol’s executive team brings, and we have been impressed with the transparency and quality control that Elixinol is able to provide. It allows us to confidently say that we are bringing the best CBD available anywhere to our customers.”
In addition to distributing products to retail locations, MAF Distributors works to educate health professionals, organizations, customers and retailers about the benefits of CBD. The company recently launched Puerto Rico’s first Spanish-language call center for general education on CBD and Elixinol products, at 1-787-338-0107.
MAF also has an educational web site at:
www.micannabidiol.com
A site focused on Elixinol products:
www.tucbd.com
And a Facebook Fan Page:
www.facebook.com/elixinolpr
About Elixinol:
Elixinol LLC is based in Colorado and has experienced significant demand for its innovative cannabinoid products. Elixinol was founded by a group of passionate leaders committed to bringing forth education and awareness on how people can live long, healthy lives and to naturally reduce the amount of disease we see in our world today. They source their products from the finest regions throughout the world with the highest quality organically grown plants and have state of the art product formulation and manufacturing facilities. Elixinol recently introduced Hemp Oil Liposomes, with superior bioavailability and real fruit flavor.
- Facebook: https://www.facebook.com/Elixinol
- Twitter: https://twitter.com/elixinolcbd
- Instagram: http://instagram.com/elixinol
- Internet: http://www.elixinol.com
All Elixinol’s products are created and distributed in full compliance with State and Federal laws. The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficiency of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. If you are taking any medication or are under treatment for any disease, please consult your health care professional about potential interactions or other possible complications before using these products. The Federal Food, Drug and Cosmetic Act requires this notice.
Contact Elixinol LLC: 844-804-3504 or [email protected]


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



